We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Quantitating myocardial fibrosis using extracellular extravascular volume determined from computed tomography myocardial perfusion imaging

    Purpose

    Both of extracellular extravascular volume (EEV) and extracellular volume fraction (ECV) were proposed to quantify enlargement of myocardial...

    Na Li, **n Zhang, ... Heshui Shi in BMC Medical Imaging
    Article Open access 12 February 2024
  2. Myocardial bridging in obstructive hypertrophic cardiomyopathy: a risk factor for myocardial fibrosis

    Background

    Myocardial bridging (MB) is common in patients with hypertrophic cardiomyopathy (HCM). There are sparse data on the impact of MB on...

    Changpeng Song, Shengwei Wang, ... **aohong Huang in BMC Medicine
    Article Open access 27 February 2024
  3. miRNA-146a-5p Inhibits Hypoxia-Induced Myocardial Fibrosis Through EndMT

    Cardiac Vascular disease particularly myocardial infarction (MI) is a threat to health worldwide. microRNAs (miRNAs) have been shown to regulate...

    Yan Wang, Jie Yu, ... Longjun Li in Cardiovascular Toxicology
    Article 05 January 2024
  4. Biomarkers of Myocardial Fibrosis in Diabetes, Echocardiography, and Magnetic Resonance Imaging

    Diabetes mellitus (DM) is associated with cardiomyopathy. Cardiomyopathy in DM can be from ischemic heart disease or related purely to DM-related...
    Per Lav Madsen in Biomarkers in Diabetes
    Reference work entry 2023
  5. Salvianolic acid B ameliorates myocardial fibrosis in diabetic cardiomyopathy by deubiquitinating Smad7

    Background

    Salvianolic acid B (Sal B), a water-soluble phenolic compound derived from Salvia miltiorrhiza Bunge, is commonly used in Traditional...

    Hong Luo, Lingyun Fu, ... **angchun Shen in Chinese Medicine
    Article Open access 10 December 2023
  6. No adverse association between exercise exposure and diffuse myocardial fibrosis in male endurance athletes

    The potential association between endurance exercise and myocardial fibrosis is controversial. Data on exercise exposure and diffuse myocardial...

    Kristoffer Andresen, Lars Gunnar Klæboe, ... Thor Edvardsen in Scientific Reports
    Article Open access 19 March 2024
  7. CHI3L1 promotes myocardial fibrosis via regulating lncRNA TUG1/miR-495-3p/ETS1 axis

    Abnormal levels of CHI3L1 and lnc TUG1 are often associated with myocardial fibrosis, and their specific expressions may be closely related to the...

    Yunpeng Sun, Xue Shan, ... Dashi Ma in Apoptosis
    Article 07 June 2023
  8. Novel Genetic Variants Associated with Primary Myocardial Fibrosis in Sudden Cardiac Death Victims

    Abstract

    Myocardial fibrosis is a common finding in victims of sudden cardiac death (SCD). Whole exome sequencing was performed in 127 victims of SCD...

    Sini Skarp, Anne Doedens, ... Juhani Junttila in Journal of Cardiovascular Translational Research
    Article Open access 07 June 2024
  9. CAV1 Protein Encapsulated in Mouse BMSC-Derived Extracellular Vesicles Alleviates Myocardial Fibrosis Following Myocardial Infarction by Blocking the TGF-β1/SMAD2/c-JUN Axis

    Abstract

    Extracellular vesicles (EVs) derived from mouse bone marrow mesenchymal stem cells (mBMSCs) convey the CAV1 protein, influencing the...

    Yi** Wu, Wenying Peng, ... ** Zhu in Journal of Cardiovascular Translational Research
    Article 13 December 2023
  10. Glucose fluctuations aggravate myocardial fibrosis via activating the CaMKII/Stat3 signaling in type 2 diabtetes

    Background

    Glucose fluctuations (GF) are a risk factor for cardiovascular complications associated with type 2 diabetes. However, there is a lack of...

    Lei Zhang, Huan-Huan Liu, ... Ru-**ng Wang in Diabetology & Metabolic Syndrome
    Article Open access 28 October 2023
  11. Genetics of myocardial interstitial fibrosis in the human heart and association with disease

    Myocardial interstitial fibrosis is associated with cardiovascular disease and adverse prognosis. Here, to investigate the biological pathways that...

    Victor Nauffal, Paolo Di Achille, ... Steven A. Lubitz in Nature Genetics
    Article 20 April 2023
  12. Early signs of myocardial systolic dysfunction in patients with type 2 diabetes are strongly associated with myocardial microvascular dysfunction independent of myocardial fibrosis: a prospective cohort study

    Background

    Patients with diabetes demonstrate early left ventricular systolic dysfunction. Notably reduced global longitudinal strain (GLS) is related...

    Annemie S. Bojer, Martin H. Sørensen, ... Per L. Madsen in Diabetology & Metabolic Syndrome
    Article Open access 13 February 2024
  13. Inhibition of tartrate-resistant acid phosphatase 5 can prevent cardiac fibrosis after myocardial infarction

    Background

    Myocardial infarction (MI) leads to enhanced activity of cardiac fibroblasts (CFs) and abnormal deposition of extracellular matrix...

    Shujun Yang, Liying Pei, ... Tong Wang in Molecular Medicine
    Article Open access 15 June 2024
  14. Myocardial fibrosis associates with lupus anticoagulant in patients with systemic lupus erythematosus

    Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that carries increased risk of cardiovascular disease; however, the underlying...

    Katrine A. Myhr, Amanda H. Zinglersen, ... Søren Jacobsen in The International Journal of Cardiovascular Imaging
    Article Open access 09 October 2023
  15. Targeting myocardial inflammation: investigating the therapeutic potential of atrial natriuretic peptide in atrial fibrosis

    Background

    Atrial Fibrillation (AF), a prevalent arrhythmic condition, is intricately associated with atrial fibrosis, a major pathological...

    Nana Zhu, Tianlun Li, ... Zhaoliang Shan in Molecular Biology Reports
    Article Open access 15 April 2024
  16. Diffuse myocardial fibrosis is uncommon in people with perinatally acquired human immunodeficiency virus infection

    Background

    Cardiovascular disease (CVD) remains a leading cause of death in people living with HIV. Myocardial fibrosis is well-described in HIV...

    Jason L. Williams, Frances Hung, ... Gerald S. Bloomfield in AIDS Research and Therapy
    Article Open access 04 March 2024
  17. HTRA1-driven detachment of type I collagen from endoplasmic reticulum contributes to myocardial fibrosis in dilated cardiomyopathy

    Background

    The aberrant secretion and excessive deposition of type I collagen (Col1) are important factors in the pathogenesis of myocardial fibrosis...

    Hongjie Shi, Ming Yuan, ... **** Liu in Journal of Translational Medicine
    Article Open access 22 March 2024
  18. Optimized New Shengmai Powder modulation of cAMP/Rap1A signaling pathway attenuates myocardial fibrosis in heart failure

    Background

    Optimized New Shengmai Powder (ONSMP) is a traditional Chinese medicine formula with significant anti-heart failure and myocardial fibrosis...

    Zeyu Zhang, Zhe xu, ... **gyuan Mao in Chinese Medicine
    Article Open access 24 February 2024
  19. Finerenone attenuates myocardial apoptosis, metabolic disturbance and myocardial fibrosis in type 2 diabetes mellitus

    Background

    Finerenone is a third-generation mineralocorticoid receptor antagonists, which has shown good cardiac function improvement in patients with...

    Tao **, **angrui Fu, ... Fengshuang An in Diabetology & Metabolic Syndrome
    Article Open access 29 April 2023
  20. Impaired Myocardial Work in Children with Hypertrophic Cardiomyopathy and Left Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging

    Echocardiography is pivotal for diagnosis and monitoring of hypertrophic cardiomyopathy (HCM) and can evaluate myocardial function using myocardial...

    Xander Jacquemyn, Rita Long, ... Shelby Kutty in Pediatric Cardiology
    Article 17 June 2024
Did you find what you were looking for? Share feedback.